Investor

Client Type

Investor

Opportunity Assessment / Due Diligence
Required independent perspective on the opportunity for a novel drug-device combination product

Needs

A private equity firm required an external and independent assessment of the opportunity for a novel drug-device combination product in the CNS space to inform future investment.

Why ClearView

Our extensive experience in the space, familiarity with the key commercial issues associated with the drug-device combination, and ability to bring an unbiased perspective to the project were considered differentiating.